<code id='1A836A8F65'></code><style id='1A836A8F65'></style>
    • <acronym id='1A836A8F65'></acronym>
      <center id='1A836A8F65'><center id='1A836A8F65'><tfoot id='1A836A8F65'></tfoot></center><abbr id='1A836A8F65'><dir id='1A836A8F65'><tfoot id='1A836A8F65'></tfoot><noframes id='1A836A8F65'>

    • <optgroup id='1A836A8F65'><strike id='1A836A8F65'><sup id='1A836A8F65'></sup></strike><code id='1A836A8F65'></code></optgroup>
        1. <b id='1A836A8F65'><label id='1A836A8F65'><select id='1A836A8F65'><dt id='1A836A8F65'><span id='1A836A8F65'></span></dt></select></label></b><u id='1A836A8F65'></u>
          <i id='1A836A8F65'><strike id='1A836A8F65'><tt id='1A836A8F65'><pre id='1A836A8F65'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:66
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Medicare slashes safety net hospital payments by nearly $1 billion
          Medicare slashes safety net hospital payments by nearly $1 billion

          Thefederalgovernmentwillpayhospitalsthattreatpooranduninsuredpatientsalmost$1billionlessnextyear.Ado

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          H.R. 3 is the wrong path to lower drug costs

          Fromleft,Rep.RichardNeal(D-Mass.)speaksasRep.FrankPallone(D-N.J.)andHouseSpeakerNancyPelosi(D-Calif.